These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8418030)

  • 1. Doxazosin and captopril in mildly hypercholesterolemic hypertensive patients. The Doxazosin-Captopril in Hypercholesterolemic Hypertensives Study.
    Ferrara LA; Di Marino L; Russo O; Marotta T; Mancini M
    Hypertension; 1993 Jan; 21(1):97-104. PubMed ID: 8418030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Principal results of the Hypertension and Lipid Trial (HALT): a multicenter study of doxazosin in patients with hypertension.
    Levy D; Walmsley P; Levenstein M
    Am Heart J; 1996 May; 131(5):966-73. PubMed ID: 8615318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of doxazosin, an alpha 1-blocker, on serum lipids in hypertensive patients.
    Ishimitsu T; Yagi S; Sugishita Y; Fujimura A; Ebihara A; Sakamaki T; Murata K; Saito A
    Hypertens Res; 1996 Mar; 19(1):43-9. PubMed ID: 8829823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing reduction in blood pressure and left ventricular mass in hypertensive type-1 diabetic patients using captopril or doxazosin for 6 months.
    Gerdts E; Svarstad E; Aanderud S; Myking OL; Lund-Johansen P; Omvik P
    Am J Hypertens; 1998 Oct; 11(10):1178-87. PubMed ID: 9799034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placebo-controlled trial of doxazosin in management of patients with hypertension and hypercholesterolaemia.
    Macphee GJ; Curzio J; Farish E; Reid JL; Elliott HL
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):429-33. PubMed ID: 1279288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 5-year comparison of doxazosin and atenolol in patients with mild-to-moderate hypertension: effects on blood pressure, serum lipids, and coronary heart disease risk.
    Daae LN; Westlie L
    Blood Press; 1998 Jan; 7(1):39-45. PubMed ID: 9551876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of captopril to reduce serum lipids in hypertensive patients with hyperlipidemia.
    Costa FV; Borghi C; Mussi A; Ambrosioni E
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):221S-223S. PubMed ID: 3046628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of doxazosin therapy on glucose tolerance and lipid metabolism in hypertensive patients with impaired glucose tolerance.
    Shionoiri H; Ashino K; Yamanaka K; Shindo K; Hiroto S; Arita T
    Clin Ther; 1997; 19(3):527-36. PubMed ID: 9220217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of treatment with verapamil SR and captopril on the lipid profile of hypertensive patients.
    Catalano M; Cislaghi C; Carzaniga G; Aronica A; Seregni R; Libretti A
    Drugs; 1992; 44 Suppl 1():88-93. PubMed ID: 1283590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of doxazosin and hydrochlorothiazide on lipid levels in Korean patients with essential hypertension.
    Jones DW; Sands CD
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):431-7. PubMed ID: 7504134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal hemodynamic effects of captopril and doxazosin during slight physical activity in hypertensive patients with type-1 diabetes mellitus.
    Svarstad E; Gerdts E; Omvik P; Ofstad J; Iversen BM
    Kidney Blood Press Res; 2001; 24(1):64-70. PubMed ID: 11174009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of doxazosin and hydrochlorothiazide on serum lipids and blood pressure in essential hypertension.
    Trost BN; Weidmann P; Riesen W; Claessens J; Streulens Y; Nelemans F
    Am J Cardiol; 1987 May; 59(14):99G-104G. PubMed ID: 2884861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid profile and antihypertensive efficacy in hyperlipidemic hypertensive patients: comparison of rilmenidine and captopril.
    Scemama M; Février B; Beucler I; Dairou F
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S34-9. PubMed ID: 8642803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative effects of captopril and atenolol on lipid metabolism in hypertensive hypercholesterolemic patients treated with pravastatin. A multicenter controlled trial].
    Witchitz S; Provendier O; Arsenescu I
    Presse Med; 1996 Dec; 25(40):2013-6. PubMed ID: 9082374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of doxazosin and atenolol on blood pressure and blood lipids: a one-year, double-blind study in 228 hypertensive patients.
    Talseth T; Westlie L; Daae L; Vatle S
    Am Heart J; 1988 Dec; 116(6 Pt 2):1790-6. PubMed ID: 2904752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative trial of doxazosin and atenolol on cardiovascular risk reduction in systemic hypertension. The Alpha Beta Canada Trial Group.
    Carruthers G; Dessain P; Fodor G; Newman C; Palmer W; Sim D
    Am J Cardiol; 1993 Mar; 71(7):575-81. PubMed ID: 8438744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of doxazosin in mild to moderate hypertensive patients with insulin-dependent diabetes mellitus.
    Calò L; Davis PA; Cantaro S; Bonfante L; Castrignano R; Carraro G; D'Angelo A
    Acta Diabetol; 1998 Jul; 35(2):96-100. PubMed ID: 9747962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of rilmenidine (hyperium) on lipid balance in hyperlipidemic hypertensive patients. Randomized, controlled, double-blind 8-week study vs. captopril in parallel groups].
    Scemama M; Février B; Beucler I; Dairou F
    Ann Cardiol Angeiol (Paris); 1996 Dec; 45(10):595-601. PubMed ID: 9033699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and alpha-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension.
    Giordano M; Matsuda M; Sanders L; Canessa ML; DeFronzo RA
    Diabetes; 1995 Jun; 44(6):665-71. PubMed ID: 7789631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertension.
    Frick MH; Cox DA; Himanen P; Huttunen M; Pitkäjärvi T; Pörsti P; Pöyhönen L; Pyykönen ML; Reinikainen P; Salmela P
    Am J Cardiol; 1987 May; 59(14):61G-67G. PubMed ID: 2884854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.